SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?


To: Bo Didley who wrote (3802)3/17/2001 10:06:28 PM
From: StockDung  Respond to of 5582
 
"The only thing that Gum Tech is giving up is the ability to manufacture other gum products and any growth in the P&G contract"

messages.yahoo.com

Where is smucko Dan Zimmerman these days? Where is his great analysis of GUMM's future with P and G?



To: Bo Didley who wrote (3802)5/10/2001 2:41:29 PM
From: Sir Auric Goldfinger  Read Replies (1) | Respond to of 5582
 
Hey Schmo Bidley, make up some GUMMy lies: "Colgate-Palmolive May Test Market Chewing Gum in Coming Months

New York, May 10 (Bloomberg) -- Colgate-Palmolive Co., the
largest maker of toothpaste, may test market dental chewing gum.
``I wouldn't be surprised in the next little while if you saw
some test markets somewhere in the world,'' Chairman and Chief
Executive Reuben Mark said at the company's annual meeting in New
York. He declined to give further details, noting after his
presentation that ``You'll see it when you see it.''
The new product would compete with gums such as
GlaxoSmithKline Plc's Aquafresh Dental Gum, introduced last year.
Colgate, whose toothpaste sales surpassed those of Procter &
Gamble Co.'s Crest in late 1997, has 34.8 percent of U.S.
toothpaste sales, Mark said.
Colgate is ``shooting'' to have 60 percent gross profit, a
measure of how much it makes on each dollar of sales, Mark said.
The company reached its goal of having 55 percent by 2002 in the
first quarter this year. Last month, spokeswoman Ann Crawford said
the company expects to reach 60 percent earlier than its original
2008 goal.
Shares of New York-based Colgate rose 41 cents to $57.80 in
midafternoon trading. They had fallen 11 percent this year.

--Courtney Schlisserman in New York, (212) 893-4069 or
cschlisserma@bloomberg.net, through the Princeton newsroom
(609) 279-4000/kak